These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 6095372

  • 1. Experience in the radical radiotherapy of cancer in the bilharzial bladder: the use of misonidazole.
    Awwad HK, Akhoush H, El-Merzabani M, El Badawy S, Barsoum M, el Baki HA.
    Radiother Oncol; 1984 Jun; 2(1):1-8. PubMed ID: 6095372
    [Abstract] [Full Text] [Related]

  • 2. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
    Awwad HK, El Merzabani MM, El Badawy S, Ezzat S, Akoush H, Abd El Moneim H, Saiid A, Soliman O, Khafagy M, Burgers MV.
    Cancer Clin Trials; 1980 Jun; 3(3):275-80. PubMed ID: 7438324
    [Abstract] [Full Text] [Related]

  • 3. The use of misonidazole in association with a three-fractions per day regimen in advanced head and neck epidermoid cancer. A pilot study.
    Awwad HK, Barsoum M, El Merzabani M, Omar S, El Badawy S, Ezzat S, El Baki HA, Zaki A.
    Am J Clin Oncol; 1983 Feb; 6(1):91-7. PubMed ID: 6301258
    [Abstract] [Full Text] [Related]

  • 4. Postoperative radiotherapy of carcinoma in bilharzial bladder using a three-fractions per day regimen.
    Zaghloul MS, Awwad HK, Soliman O, Omar S, el Badawy S, Barsoum M, Mocktar N, Amer F.
    Radiother Oncol; 1986 Aug; 6(4):257-65. PubMed ID: 3534966
    [Abstract] [Full Text] [Related]

  • 5. Radical irradiation and misonidazole for T2 grade III and T3 bladder cancer: 2 year follow-up.
    Abratt RP, Barnes DR, Hammond JA, Sarembok LA, Tucker RD, Williams AM.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1719-20. PubMed ID: 6384160
    [Abstract] [Full Text] [Related]

  • 6. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer.
    Br J Radiol; 1984 Jul; 57(679):585-95. PubMed ID: 6329395
    [Abstract] [Full Text] [Related]

  • 7. Radical irradiation and misonidazole in the treatment of T2 grade III and T3 bladder cancer.
    Abratt RP, Sealy R, Tucker RD, Williams MA, Barnes DR, Johnson MB, Green JA, Cridland JS.
    Int J Radiat Oncol Biol Phys; 1983 May; 9(5):629-32. PubMed ID: 6853264
    [Abstract] [Full Text] [Related]

  • 8. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatment of Cancer).
    Van den Bogaert W, van der Schueren E, Horiot JC, Chaplain G, Arcangeli G, Gonzalez D, Svoboda V.
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1649-55. PubMed ID: 7153077
    [Abstract] [Full Text] [Related]

  • 9. Treatment of bladder carcinoma with irradiation combined with misonidazole.
    Papavasiliou C, Yiogarakis D, Davillas N, Seretakis L, Pappas J, Licourinas M, Theodorou C, Stathopoulos P, Katsoyianni C, Thanos A.
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1631-3. PubMed ID: 6358156
    [Abstract] [Full Text] [Related]

  • 10. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
    Mohiuddin M, Kramer S, Phillips T, Soberon M, Forgione H.
    Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
    [Abstract] [Full Text] [Related]

  • 11. Postoperative radiotherapy of carcinoma in bilharzial bladder: improved disease free survival through improving local control.
    Zaghloul MS, Awwad HK, Akoush HH, Omar S, Soliman O, el Attar I.
    Int J Radiat Oncol Biol Phys; 1992 Oct; 23(3):511-7. PubMed ID: 1612951
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pilot study of radiotherapy with misonidazole in head and neck cancer.
    Paterson IC, Dawes PJ, Henk JM, Moore JL.
    Clin Radiol; 1981 Mar; 32(2):225-9. PubMed ID: 7214840
    [Abstract] [Full Text] [Related]

  • 14. [Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study].
    Sack H, Calcanis A, Godehardt E, Weidtman V, Zülch KJ, Ammon J, Bamberg M, Herbst M, Keim H, Kleibel F, Makoski HB, Potthoff PC, Schlegel G, Schnepper E.
    Strahlentherapie; 1982 Aug; 158(8):466-9. PubMed ID: 6753245
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A prospective randomised trial of radiation with or without oral and intravesical misonidazole for bladder cancer.
    Abratt RP, Craighead P, Reddi VB, Sarembock LA.
    Br J Cancer; 1991 Nov; 64(5):968-70. PubMed ID: 1931628
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Misonidazole combined with large-fraction pelvic irradiation in the treatment of patients with advanced pelvic malignancies. Preliminary report of an ongoing RTOG phase I-II study.
    Meoz RT, Spanos WJ, Doss L, Johnson R, Wasserman TH.
    Am J Clin Oncol; 1983 Aug; 6(4):417-22. PubMed ID: 6191560
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.